Trial · NCT01527006
Results by group290
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 290
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Overall seizures | -43.6 | Full Range -100 to 95.4 | Percent change |
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Overall seizures | -33.9 | Full Range -100 to 1038.9 | Percent change |
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Overall partial seizures | -82.5 | Full Range -100 to 95.4 | Percent change |
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Overall partial seizures | -46.8 | Full Range -100 to 1722.2 | Percent change |
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Overall generalized seizures | -53.1 | Full Range -100 to 188.7 | Percent change |
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Overall generalized seizures | 305.4 | Full Range -62.9 to 1277.3 | Percent change |
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Unclassified Seizures | -73.7 | Full Range -100 to 217.3 | Percent change |
| Percent Change From Baseline in Seizure Frequency Per 28 Days in Treatment Phase [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Unclassified Seizures | -67.3 | Full Range -100 to -34.6 | Percent change |
| Apparent Clearance (CL/F) of Perampanel [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Non-Inducers (N=14, 12) | 0.732 | Standard Deviation 0.374 | Liter per hour |
| Apparent Clearance (CL/F) of Perampanel [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Non-Inducers (N=14, 12) | 0.956 | Standard Deviation 0.4 | Liter per hour |
| Apparent Clearance (CL/F) of Perampanel [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Inducers (N=6, 10) | 1.73 | Standard Deviation 1.18 | Liter per hour |
| Apparent Clearance (CL/F) of Perampanel [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Inducers (N=6, 10) | 1.92 | Standard Deviation 0.517 | Liter per hour |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Overall seizures | 72.7 | Percent responders | |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Overall seizures | 53.8 | Percent responders | |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Overall partial seizures | 82.4 | Percent responders | |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Overall partial seizures | 60.9 | Percent responders | |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Overall generalized seizures | 76.9 | Percent responders | |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Overall generalized seizures | 33.3 | Percent responders | |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 2 to < 7 Years of Age) - For Core Study | Unclassified Seizures | 66.7 | Percent responders | |
| 50% Responder Rate During the Maintenance Period-LOCF [Core Study] | Cohort ( ≥ 7 to < 12 Years of Age) - For Core Study | Unclassified Seizures | 100 | Percent responders |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01527006/results